Newsbytes
  • India
  • Business
  • World
  • Politics
  • Sports
  • Science
  • Entertainment
  • Auto
  • Lifestyle
  • Inspirational
  • Career
  • Bengaluru
  • Delhi
  • Mumbai
  • Videos
  • Phone Reviews
  • Find Cricket Statistics
Hindi
More
Newsbytes
Hindi
Newsbytes
User Placeholder

Hi,

Logout


India
Business
World
Politics
Sports
Science
Entertainment
Auto
Lifestyle
Inspirational
Career
Bengaluru
Delhi
Mumbai
Videos
Phone Reviews
Find Cricket Statistics

More Links
  • Videos

Download Android App

Follow us on
  • Facebook
  • Twitter
  • Linkedin
  • Youtube
 
Home / News / Science News / Applying for Covishield's emergency approval in 2 weeks: SII
  • Science

    Applying for Covishield's emergency approval in 2 weeks: SII

    Siddhant Pandey
    Written by
    Siddhant Pandey
    Twitter
    Last updated on Nov 28, 2020, 09:11 pm
    Applying for Covishield's emergency approval in 2 weeks: SII
  • The CEO of the Serum Institute of India (SII), Adar Poonawalla, on Saturday said that the company will seek the emergency-use authorization of the coronavirus vaccine 'Covishield' soon.

    Poonawalla made the announcement after Prime Minister Narendra Modi visited the SII in Pune earlier on Saturday.

    The PM was on a three-city tour, reviewing the development of COVID-19 vaccines at three facilities.

  • In this article
    Indian government may buy 300-400 million doses by July: Poonawalla No formal deal with India yet, says Poonawalla What is Covishield? Modi visited SII earlier today India, COVAX countries our priority: Poonawalla
  • Details

    Indian government may buy 300-400 million doses by July: Poonawalla

    Indian government may buy 300-400 million doses by July: Poonawalla
  • Poonawalla said, "We are in the process of applying for emergency use authorization of Covishield in the next two weeks."

    Covishield has been developed at SII with a master seed from pharma giant AstraZeneca and Oxford University.

    Speaking on advance purchase deals with India, Poonawalla said the government has indicated that it would buy 300-400 million doses by July 2021.

  • Quote

    No formal deal with India yet, says Poonawalla

  • Poonawalla said, "As of now, we don't have anything in writing with the government of India on how many doses they will purchase but the indication is that it would be 300-400 million doses by July 2021."

  • Vaccine

    What is Covishield?

    What is Covishield?
  • The vaccine has been made from a weakened, genetically-modified version of a common cold virus, or adenovirus, that infects chimpanzees, but cannot grow in the human body.

    It has shown 90% and 62% efficacy in two dosing regimens, reflecting an average efficacy of 70%.

    A first batch of 100 million doses—for priority groups—is expected by January, while broader access is likely by April.

  • Recent news

    Modi visited SII earlier today

    Modi visited SII earlier today
  • PM Modi had visited SII in Pune, along with Bharat Biotech in Hyderabad and Zydus Cadila in Ahmedabad, earlier on Saturday to review the development of COVID-19 vaccines.

    Poonawalla said Modi is "extremely knowledgable" on vaccines and they had to explain very little to him, except when detailing different variable vaccines and the possible challenges ahead.

  • Information

    India, COVAX countries our priority: Poonawalla

  • Poonawalla said the vaccine will initially be distributed only in India, and later the SII will look at countries that have partnered with the global COVAX facility. He said, "Our priority is India and COVAX countries."

  • Narendra Modi
  • Ahmedabad
  • Oxford University
  • Zydus Cadila
  • Coronavirus
  •  
Latest News
  • 'Mission Majnu': Sidharth Malhotra sustains injury, resumes shoot post aid
    'Mission Majnu': Sidharth Malhotra sustains injury, resumes shoot post aid
    Entertainment
  • COVID-19 negative report must to visit Jagannath Temple
    COVID-19 negative report must to visit Jagannath Temple
    India
  • Maharashtra: Traders wait for respite following COVID-19 curbs
    Maharashtra: Traders wait for respite following COVID-19 curbs
    India
  • Katrina Kaif tests positive for coronavirus, in home isolation
    Katrina Kaif tests positive for coronavirus, in home isolation
    Entertainment
  • TMC candidate Sujata Mondal attacked by BJP workers, alleges party
    TMC candidate Sujata Mondal attacked by BJP workers, alleges party
    Politics
Related Timelines
  • Adar Poonawalla, WHO scientist warn of delays in vaccine production
    Adar Poonawalla, WHO scientist warn of delays in vaccine production
    World
  • SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
    SII, Bharat Biotech ensure 'smooth roll out' of vaccines globally
    India
  • 'Finally paid off,' says Adar Poonawalla after Covishield gets approval
    'Finally paid off,' says Adar Poonawalla after Covishield gets approval
    India
  • SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI
    SII's Covishield, Bharat Biotech's COVAXIN granted emergency approval, says DCGI
    India
Trending Topics
Samsung Elon Musk Apple OnePlus Mobiles Android TV Smart TV Latest Gadget Launch MediaTek Dimensity 1000+ COVAXIN Latest Tech News Upcoming Mobile Phones
Next News Article
Share
Cancel

Want to share it with your friends too?

Facebook Whatsapp Twitter Linkedin
Copied

Love Science news?

Subscribe to stay updated.

Science Thumbnail
India News Business News World News Politics News Sports News Science News Entertainment News Auto News Lifestyle News Inspirational News
Career News Bengaluru News Delhi News Mumbai News Bharti Airtel Mukesh Ambani Indian Premier League Samsung Virat Kohli Rohit Sharma
Cricket News YouTube Hollywood News WhatsApp Bollywood News ISRO Elon Musk Yoga Honda Batman
Football News BMW Vaccine Reliance Jio OPPO Food News, Healthy Recipes Apple Royal Challengers Bangalore Toyota Fashion Tips
Mercedes Isha Ambani India Vs England Cricket OnePlus Mobiles Android TV Smart TV Marvel Comics Avengers Neha Kakkar Chris Morris
Big Bang Theory X-Men TATA Royal Enfield
About Us Privacy Policy Terms & Conditions Contact Us News Reviews News Archive Topics Archive Find Cricket Statistics
Follow us on
Facebook Twitter Linkedin Youtube
All rights reserved © NewsBytes 2021